Mice given GLP-1 drugs tend to avoid nicotine, suggesting these drugs might reduce the appeal of nicotine.

The study found that a drug that activates GLP-1 receptors makes nicotine less rewarding to mice by reducing dopamine release in their brain’s pleasure center, which likely makes them avoid nicotine.